ZA961342B - Benzothiazine dioxides as endthelin antagonists - Google Patents

Benzothiazine dioxides as endthelin antagonists

Info

Publication number
ZA961342B
ZA961342B ZA961342A ZA961342A ZA961342B ZA 961342 B ZA961342 B ZA 961342B ZA 961342 A ZA961342 A ZA 961342A ZA 961342 A ZA961342 A ZA 961342A ZA 961342 B ZA961342 B ZA 961342B
Authority
ZA
South Africa
Prior art keywords
antagonists
endthelin
endothelin
preparation
benzothiazine dioxides
Prior art date
Application number
ZA961342A
Other languages
English (en)
Inventor
Kent Alan Berryman
Amy Mae Bunker
Annette Marian Doherty
Jeremy John Edmunds
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA961342B publication Critical patent/ZA961342B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Dental Preparations (AREA)
  • Polyesters Or Polycarbonates (AREA)
ZA961342A 1995-02-21 1996-02-20 Benzothiazine dioxides as endthelin antagonists ZA961342B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/393,143 US5599811A (en) 1995-02-21 1995-02-21 Benzothiazine dioxides as endothelin antagonists

Publications (1)

Publication Number Publication Date
ZA961342B true ZA961342B (en) 1996-08-26

Family

ID=23553452

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961342A ZA961342B (en) 1995-02-21 1996-02-20 Benzothiazine dioxides as endthelin antagonists

Country Status (27)

Country Link
US (1) US5599811A (ja)
EP (1) EP0811001B1 (ja)
JP (1) JPH11501013A (ja)
KR (1) KR19980702358A (ja)
CN (1) CN1071327C (ja)
AT (1) ATE207911T1 (ja)
AU (1) AU720036B2 (ja)
BG (1) BG62613B1 (ja)
CA (1) CA2211027A1 (ja)
CZ (1) CZ294412B6 (ja)
DE (1) DE69616515T2 (ja)
DK (1) DK0811001T3 (ja)
EE (1) EE03564B1 (ja)
ES (1) ES2167544T3 (ja)
FI (1) FI973380A (ja)
GE (1) GEP20001969B (ja)
HU (1) HUP9800273A3 (ja)
NO (1) NO308897B1 (ja)
NZ (1) NZ302116A (ja)
PL (1) PL321866A1 (ja)
PT (1) PT811001E (ja)
RO (1) RO116898B1 (ja)
RU (1) RU2164225C2 (ja)
SK (1) SK284275B6 (ja)
UA (1) UA47424C2 (ja)
WO (1) WO1996026195A1 (ja)
ZA (1) ZA961342B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US5945448A (en) * 1995-06-02 1999-08-31 Shionogi & Co., Ltd. Brain edema inhibitor
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US6432994B1 (en) 1997-04-28 2002-08-13 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
CA2295239A1 (en) 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
PL338983A1 (en) * 1997-09-05 2000-12-04 Warner Lambert Co Some dioxides of benzothiazine as antagonists of endothelin and methods of obtaining them
GB2337048B (en) * 1998-05-05 2000-06-28 Warner Lambert Co 2,1,3-Benzothiadiazole containing endothelin antagonists
WO2001091736A2 (en) * 2000-05-31 2001-12-06 Warner-Lambert Company Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
US20020115661A1 (en) * 2000-12-07 2002-08-22 Keller Laurence Harvey Method for treating chronic obstructive pulmonary disease
BRPI0709950A2 (pt) * 2006-04-13 2011-08-02 Actelion Pharmaceuticals Ltd uso de bosentan na preparação de um medicamento para o tratamento de fibrose pulmonar idiopática em estágio precoce e uso de antagonista do receptor endotelin
FR2942797B1 (fr) * 2009-03-03 2011-04-29 Pf Medicament Derives de benzothiazines, leur preparation et leur application a titre de medicaments
US10865201B2 (en) * 2016-09-12 2020-12-15 Valo Health, Inc. Bicyclic compounds useful as GPR120 modulators
CN114671827B (zh) * 2020-12-24 2024-09-20 杭州百新生物医药科技有限公司 邻苯甲酰磺酰亚胺类衍生物及其应用
CN112521384B (zh) * 2021-01-13 2021-11-02 湖北大学 溶剂热一锅法合成苯并噻嗪并环戊二烯衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237473A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
JPH0441483A (ja) * 1990-06-07 1992-02-12 Tanabe Seiyaku Co Ltd ベンゾチアジン誘導体及びその製法
RU2125980C1 (ru) * 1991-11-05 1999-02-10 Смитклайн Бичам Корпорейшн Антагонисты эндотелиновых рецепторов, фармкомпозиция, способ их получения, способ подавления эндотелиновых рецепторов
US5389620A (en) * 1993-08-18 1995-02-14 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives

Also Published As

Publication number Publication date
UA47424C2 (uk) 2002-07-15
HUP9800273A3 (en) 1999-09-28
DE69616515T2 (de) 2002-05-16
WO1996026195A1 (en) 1996-08-29
CZ294412B6 (cs) 2004-12-15
BG101867A (en) 1998-10-30
NO308897B1 (no) 2000-11-13
KR19980702358A (ko) 1998-07-15
AU720036B2 (en) 2000-05-18
NO973822D0 (no) 1997-08-20
ATE207911T1 (de) 2001-11-15
RU2164225C2 (ru) 2001-03-20
CN1071327C (zh) 2001-09-19
CZ260797A3 (cs) 1998-06-17
ES2167544T3 (es) 2002-05-16
GEP20001969B (en) 2000-03-05
FI973380A (fi) 1997-08-20
DK0811001T3 (da) 2002-02-18
MX9706024A (es) 1997-11-29
CA2211027A1 (en) 1996-08-29
AU4770396A (en) 1996-09-11
NZ302116A (en) 1998-06-26
NO973822L (no) 1997-08-21
SK114697A3 (en) 1998-08-05
PT811001E (pt) 2002-04-29
EE03564B1 (et) 2001-12-17
HUP9800273A2 (hu) 1999-07-28
CN1180351A (zh) 1998-04-29
EE9700147A (et) 1997-12-15
RO116898B1 (ro) 2001-07-30
US5599811A (en) 1997-02-04
DE69616515D1 (de) 2001-12-06
JPH11501013A (ja) 1999-01-26
SK284275B6 (sk) 2004-12-01
EP0811001A1 (en) 1997-12-10
EP0811001B1 (en) 2001-10-31
BG62613B1 (bg) 2000-03-31
PL321866A1 (en) 1997-12-22
FI973380A0 (fi) 1997-08-18

Similar Documents

Publication Publication Date Title
ZA961342B (en) Benzothiazine dioxides as endthelin antagonists
IL140622A0 (en) Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
ATE195948T1 (de) Endothelinantagonisten
IL117209A0 (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
MY116277A (en) Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
BG104022A (en) New beta-amino and beta-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists
PT78161A (de) Verfahren zur herstellung von 4-amino-6,7-dimethoxy-2-<4-(furo--2-yl)-piperazin-1-yl>-chinazolin und dessen physiologisch annehmabarer salze
BG101431A (en) the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR